Clinical Trial Update: Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine plus platinum salt plus bevacizumab for metastatic collecting duct carcinoma of the kidney has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Collecting Duct Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Gemcitabine (Gemcitabine)
• Platinum Salt (platinum-based chemotherapy)

Snippet

Sponsor: UNICANCER | Conditions: Collecting Duct Carcinoma (Kidney) | Phase 2 | Status: COMPLETED